Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Intermediate Filaments01:31

Types of Intermediate Filaments

5.1K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
5.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fast and compact scatterometer for ex vivo qualification of low-scattering biological samples.

The Review of scientific instruments·2026
Same author

Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study.

Hematological oncology·2024
Same author

Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin.

British journal of haematology·2024
Same author

Outcomes of lung transplantation for pleuroparenchymal fibroelastosis: A French multicentric retrospective study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024
Same author

On the estimation of the effect of weight change on a health outcome using observational data, by utilising the target trial emulation framework.

International journal of obesity (2005)·2023
Same author

French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.

La Revue de medecine interne·2023

Related Experiment Video

Updated: Mar 14, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K

[Type I interferonopathies. Literature review].

C Picard1, A Belot1

  • 1Service de rhumatologie pédiatrique, hôpital femme-mère-enfant, hospices civils de Lyon, 59, boulevard Pinel, 69500 Bron, France.

La Revue De Medecine Interne
|September 24, 2016
PubMed
Summary

Type I interferonopathies are inherited inflammatory disorders caused by excess interferon. These rare Mendelian diseases share symptoms like neurological and skin issues, and a positive interferon signature, with targeted therapies showing promise.

Keywords:
Autoimmune diseaseGeneticsGénétiqueInterféron de type IMaladie auto-immunePattern recognition receptorsPediatricsPédiatrieType I interferon

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.6K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.4K

Related Experiment Videos

Last Updated: Mar 14, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.6K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.4K

Area of Science:

  • Genetics
  • Immunology
  • Neurology

Background:

  • Recent advances in genetics have identified a new class of inherited inflammatory disorders.
  • These disorders, termed type I interferonopathies, are characterized by the overproduction of interferon.
  • They represent a heterogeneous group of Mendelian diseases with diverse clinical manifestations.

Purpose of the Study:

  • To summarize the key features of type I interferonopathies.
  • To highlight shared clinical and biological characteristics.
  • To discuss current treatment challenges and future therapeutic directions.

Main Methods:

  • Literature review of genetic and clinical data.
  • Analysis of shared diagnostic markers, including interferon signature.
  • Review of therapeutic strategies targeting interferon pathways.

Main Results:

  • Type I interferonopathies present with varied symptoms, often starting in childhood but diagnosable later.
  • Common features include a positive interferon (IFN) signature, neurological involvement, and cutaneous manifestations.
  • Some variants exhibit organ specificity.

Conclusions:

  • Type I interferonopathies are severe, genetically determined inflammatory conditions.
  • Targeting interferon pathways offers a promising therapeutic avenue for these challenging diseases.